Header

UZH-Logo

Maintenance Infos

Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10-year-old girl


Knöpfel, Nicole; Theiler, Martin; Luchsinger, Isabelle; Hafner, Bettina; Brunner, Corinne; Kolm, Isabel; Weibel, Lisa (2020). Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10-year-old girl. Pediatric Dermatology, 37(6):1183-1184.

Abstract

We report the case of a 10-year-old girl with bullous Sweet syndrome, recalcitrant to high-dose systemic corticosteroids. Subsequent treatment with infliximab resulted in a rapid improvement in cutaneous lesions and systemic symptoms. Cutis laxa was noted in the healed skin. We propose early second-line treatment with infliximab in children with steroid-refractory Sweet syndrome.

Abstract

We report the case of a 10-year-old girl with bullous Sweet syndrome, recalcitrant to high-dose systemic corticosteroids. Subsequent treatment with infliximab resulted in a rapid improvement in cutaneous lesions and systemic symptoms. Cutis laxa was noted in the healed skin. We propose early second-line treatment with infliximab in children with steroid-refractory Sweet syndrome.

Statistics

Citations

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Clinic for Surgery
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Pediatrics, Perinatology and Child Health
Health Sciences > Dermatology
Language:English
Date:November 2020
Deposited On:10 Feb 2021 13:40
Last Modified:11 Feb 2021 21:00
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0736-8046
OA Status:Closed
Publisher DOI:https://doi.org/10.1111/pde.14356
PubMed ID:32901971

Download

Full text not available from this repository.
View at publisher

Get full-text in a library